- authorisedTherapeutic confirmatory (Phase III)
BeCALM - Brentuximab vedotin in CutAneous T-cell Lymphomas (CTCL): post-allogeneic hematopoietic stem cell transplant Maintenance
This study looks at whether a drug called Adcetris can help people with a rare skin cancer (cutaneous T-cell lymphoma) stay cancer-free after a stem cell transplant. We want to see if it prevents the cancer from coming back.
France - recruiting
Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients
This study looks at how advanced genetic tests (genomic sequencing) help doctors treat cancer in France. It checks if these tests improve patient care, how quickly results are ready, and how hospitals share information, helping to improve future healthcare for cancer patients.
France